Research Article

Constructed competitive endogenous RNA network and patterns of immune infiltration revealing the prognostic signature for cervical cancer

Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, No. 106, Zhongshan Road II, Yuexiu District, Guangzhou City, Guangdong Province, China

‡Luqiao Luo and Fei Qiao made equal contributions to this research

Search for more papers by this author

Fei Qiao‡

Department of General Practice, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, No. 106, Zhongshan Road II, Yuexiu District, Guangzhou City, Guangdong Province, China

‡Luqiao Luo and Fei Qiao made equal contributions to this research

Search for more papers by this author

Ke Zhou

Department of Obstetrics & Gynecology, Ganzhou Hospital of Guangdong Provincial People's Hospital (Ganzhou Municipal Hospital), Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, No. 106, Zhongshan Road II, Yuexiu District, Guangzhou City, Guangdong Province, China

Search for more papers by this author

Qiang Tu

Search for more papers by this author

Jiao He

Search for more papers by this author

Haoqi Huang

Search for more papers by this author

Chao Liu

Search for more papers by this author

Huihua Cai

*Author for correspondence: Tel.: +86 135 7046 9142;

E-mail Address: caihuihua@gdph.org.cn

Search for more papers by this author

Published Online:15 Jan 2024https://doi.org/10.2217/epi-2023-0336

View article

Abstract

Aim: To investigate the relationship between potential abnormal epigenetic modification and immune cell infiltration in patients with cervical carcinoma. Materials & methods: RNA expression profiles from The Cancer Genome Atlas database were used to explore the relationship between key biomarkers and tumor-infiltrating immune cells and for clinical specimen validation. Results: Two nomogram models were developed, one with specific ceRNA and the other based on biological markers of related tumor-infiltrating immune cells. Moreover, a key biomarker (RIPOR2), which was significantly relevant to CD8 T cells. Conclusion: RIPOR2 and CD8 T cells play a crucial role in the development and progression of cervical carcinoma, suggesting their potential as markers for guiding future therapeutic strategies.

Graphical abstract

Keywords:

Papers of special note have been highlighted as: •• of considerable interest

References

1. Xi C, Shen JJ, Burston B et al. Epidemiological/Disease and Economic Burdens of Cervical Cancer in 2010-2014: Are Younger Women at Risk?. Healthcare (Basel). 11(1), 144 2023).
MedlineGoogle Scholar
2. Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209–249 (2021).
MedlineGoogle Scholar
3. Kessler TA. Cervical cancer: prevention and early detection. Semin. Oncol. Nurs. 33(2), 172–183 (2017).
MedlineGoogle Scholar
4. Denny L. Cervical cancer: prevention and treatment. Discov. Med. 14(75), 125–131 (2012).
MedlineGoogle Scholar
5. Sarfi M, Abbastabar M, Khalili E. Long noncoding RNAs biomarker-based cancer assessment. J. Cell. Physiol. 234(10), 16971–16986 (2019).
Medline CASGoogle Scholar
6. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146(3), 353–358 (2011). •• The hypothesis of a competitive endogenous RNA network was proposed for the first time.
Medline CASGoogle Scholar
7. Karreth FA, Pandolfi PP. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov. 3(10), 1113–1121 (2013).
Medline CASGoogle Scholar
8. Xia L, Wang H, Cai S et al. Integrated analysis of a competing endogenous RNA network revealing a prognostic signature for cervical cancer. Front. Oncol. 8, 368 (2018).
MedlineGoogle Scholar
9. Mei J, Xing Y, Lv J et al. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer. Int. Immunopharmacol. 88, 106882 (2020).
Medline CASGoogle Scholar
10. Wang J, Li Z, Gao A, Wen Q, Sun Y. The prognostic landscape of tumor-infiltrating immune cells in cervical cancer. Biomed. Pharmacother. 120, 109444 (2019).
Medline CASGoogle Scholar
11. Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol. Biol. 1711, 243–259 (2018).
Medline CASGoogle Scholar
12. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1), 139–140 (2010).
Medline CASGoogle Scholar
13. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57(1), 289–300 (1995).
Google Scholar
14. Li R, Qu H, Wang S et al. GDCRNATools: an R/Bioconductor package for integrative analysis of lncRNA, miRNA and mRNA data in GDC. Bioinformatics 34(14), 2515–2517 (2018). •• Provides methodological validation for the current experiment.
MedlineGoogle Scholar
15. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27(3), 431–432 (2011).
Medline CASGoogle Scholar
16. Balachandran VP, Gonen M, Smith JJ, Dematteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 16(4), e173–e180 (2015).
MedlineGoogle Scholar
17. Zhang X, Lan Y, Xu J et al. CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 47(D1), D721–D728 (2019).
Medline CASGoogle Scholar
18. Cerami E, Gao J, Dogrusoz U et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2(5), 401–404 (2012).
MedlineGoogle Scholar
19. Liu SH, Shen PC, Chen CY et al. DriverDBv3: a multi-omics database for cancer driver gene research. Nucleic Acids Res. 48(D1), D863–D870 (2020).
Medline CASGoogle Scholar
20. Human Genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348(6235), 648–660 (2015).
MedlineGoogle Scholar
21. Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45(W1), W98–W102 (2017).
Medline CASGoogle Scholar
22. Aguirre-Gamboa R, Gomez-Rueda H, Martínez-Ledesma E et al. SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis. PLOS ONE 8(9), e74250 (2013).
Medline CASGoogle Scholar
23. Modhukur V, Iljasenko T, Metsalu T, Lokk K, Laisk-Podar T, Vilo J. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics 10(3), 277–288 (2018).
CASGoogle Scholar
24. Wang Q, Wang F, Lv J et al. Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysis. Oncol. Lett. 18(2), 1199–1206 (2019).
Medline CASGoogle Scholar
25. Yang Y, Xiao M, Song Y et al. H-score of 11β-hydroxylase and aldosterone synthase in the histopathological diagnosis of adrenocortical tumors. Endocrine 65(3), 683–691 (2019).
Medline CASGoogle Scholar
26. Karumuri R, Shah D, Arnouk H. Cornulin as a prognosticator for lymph node involvement in cutaneous squamous cell carcinoma. Cureus 14(12), e33130 (2022).
MedlineGoogle Scholar
27. Morris JA, Gayther SA, Jacobs IJ, Jones C. A Perl toolkit for LIMS development. Source Code Biol. Med. 3, 4 (2008).
MedlineGoogle Scholar
28. Newman AM, Liu CL, Green MR et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12(5), 453–457 (2015).
Medline CASGoogle Scholar
29. Karreth FA, Reschke M, Ruocco A et al. The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo. Cell 161(2), 319–332 (2015).
Medline CASGoogle Scholar
30. Cheng Z, Yu C, Cui S et al. circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nat. Commun. 10(1), 3200 (2019).
MedlineGoogle Scholar
31. Zhu H, Guo J, Shen Y et al. Functions and mechanisms of tumor necrosis factor-α and noncoding RNAs in bone-invasive pituitary adenomas. Clin. Cancer Res. 24(22), 5757–5766 (2018).
Medline CASGoogle Scholar
32. Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature 505(7483), 344–352 (2014).
Medline CASGoogle Scholar
33. Xue C, Li G, Lu J, Luo J, Jia J. Novel insights for lncRNA MAGI2-AS3 in solid tumors. Biomed. Pharmacother. 137, 111429 (2021).
Medline CASGoogle Scholar
34. Wang C, Su K, Lin H, Cen B, Zheng S, Xu X. Identification and verification of a novel MAGI2-AS3/miRNA-374-5p/FOXO1 network associated with HBV-related HCC. Cells 11(21), 3466 (2022).
Medline CASGoogle Scholar
35. Olmedo-Nieva L, Muñoz-Bello JO, Martínez-Ramírez I et al. RIPOR2 expression decreased by HPV-16 E6 and E7 oncoproteins: an opportunity in the search for prognostic biomarkers in cervical cancer. Cells 11(23), 3942 (2022).
Medline CASGoogle Scholar
36. Dakour J, Li H, Morrish DW. PL48: a novel gene associated with cytotrophoblast and lineage-specific HL-60 cell differentiation. Gene 185(2), 153–157 (1997).
Medline CASGoogle Scholar
37. Rougerie P, Largeteau Q, Megrelis L et al. Fam65b is a new transcriptional target of FOXO1 that regulates RhoA signaling for T lymphocyte migration. J. Immunol. 190(2), 748–755 (2013).
Medline CASGoogle Scholar
38. Kamphorst AO, Wieland A, Nasti T et al. Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent. Science 355(6332), 1423–1427 (2017).
Medline CASGoogle Scholar
39. Ceeraz S, Thompson CR, Beatson R, Choy EH. Harnessing CD8(+)CD28(-) regulatory T cells as a tool to treat autoimmune disease. Cells 10(11), 2973 (2021).
Medline CASGoogle Scholar

Vol. 16, No. 1

Supplemental Materials

Metrics

Downloaded 24 times

History

Received 25 September 2023

Accepted 11 December 2023

Published online 15 January 2024

Published in print January 2024

Information

Keywords

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at: www.futuremedicine.com/doi/suppl/10.2217/epi-2023-0336

Author contributions

Conceived and designed the experiments: LQ Luo, F QiaoQ, HH Cai; performed the experiments: LQ Luo, Q Tu; analyzed the data: LQ Luo, J He, C Liu; contributed reagents/materials/technical: HQ Huang; wrote the paper: LQ Luo, K Zhou; revised the manuscript: HH Cai.

Financial disclosure

This work was supported by the Medical Scientific Research Foundation of Guangdong Province, China (A2021227, A2022067). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

Ethical conduct of research

This study was approved by the Medical Research Ethics Committee of Guangdong Provincial People's Hospital (approval no. KY2020-644-01). The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations.

PDF download